JG
VIR icon

Joel Greenblatt’s Vir Biotechnology VIR Stock Holding History

Joel Greenblatt’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,148
Closed -$90.3K – 1529
2024
Q2 		$90.3K Buy
+10,148
New +$97.3K ﹤0.01% 1385
2023
Q2 		– Sell
-24,453
Closed -$569K – 1435
2023
Q1 		$569K Sell
24,453
-23,257
-49% -$595K 0.01% 915
2022
Q4 		$1.21M Sell
47,710
-24,474
-34% -$600K 0.03% 615
2022
Q3 		$1.39M Buy
72,184
+1,221
+2% +$31K 0.04% 533
2022
Q2 		$1.81M Buy
+70,963
New +$1.66M 0.06% 403
2022
Q1 		– Sell
-10,015
Closed -$419K – 1249
2021
Q4 		$419K Buy
10,015
+3,088
+45% +$121K 0.01% 834
2021
Q3 		$301K Buy
+6,927
New +$300K 0.01% 829

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Joel Greenblatt's VIR Position: Q3 2024 in Review

Joel Greenblatt sold out of Vir Biotechnology (VIR) in Q3 2024, closing a stake of 10,148 shares — an estimated $90.3K sold.

Joel Greenblatt first reported a position in VIR in Q3 2021 and held it in 7 quarters. The position peaked at $1.81M in Q2 2022. 197 funds tracked by Wall St. Rank hold VIR as of Q3 2024.

  • Joel Greenblatt reported no remaining Vir Biotechnology position as of Q3 2024 after selling out during the quarter.
  • Joel Greenblatt sold 10,148 Vir Biotechnology shares in Q3 2024, an estimated $90.3K.
  • Joel Greenblatt first reported a position in Vir Biotechnology in Q3 2021 and held it in 7 quarters.
  • Joel Greenblatt's Vir Biotechnology position peaked at $1.81M in Q2 2022.
  • 197 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2024.

Based on Gotham Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.